Milk thistle is a spiky green plant. Silymarin is a compound found in its seeds. It has been used to lower cholesterol and improve liver function. Milk thistle can be taken as a pill, powder, or extract. It can also be applied as a cream.
150 milligrams 2 to 3 times daily
What Research Shows
May Be Effective
May Not Be Effective
Not Enough Data to Assess
Editorial process and description of evidence categories can be found at EBSCO NAT Editorial Process.
It is likely safe to take milk thistle and to use it on the skin for a short time. Not enough studies have been done to say whether it is safe to use for a long period or by women who are pregnant or breastfeeding.H3
Talk to your doctor about any supplements or therapy you would like to use. Some can interfere with treatment or make conditions worse, such as:
A. Acute Hepatitis
A1. El-Kamary SS, Shardell MD, et al. A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis. Phytomedicine. 2009;16(5):391-400.
B. Breastfeeding Support
B1. Mortel M, Mehta SD. Systematic review of the efficacy of herbal galactogogues. J Hum Lact. 2013 May;29(2):154-162.
B2. Zecca E, Zuppa AA, et al. Efficacy of a galactogogue containing silymarin-phosphatidylserine and galega in mothers of preterm infants: a randomized controlled trial. Eur J Clin Nutr. 2016 Oct;70(10):1151-1154.
B3. Serrao F, Corsello M, et al. The Long-Term Efficacy of a Galactagogue Containing Sylimarin-Phosphatidylserine and Galega on Milk Production of Mothers of Preterm Infants. Breastfeed Med. 2018 Jan/Feb;13(1):67-69.
C. Decompensated Liver Cirrhosis
C1. May be improve quality of life. Fathalah WF, Abdel Aziz MA, Abou El Soud NH, El Raziky MES. High Dose of Silymarin in Patients with Decompensated Liver Disease: A Randomized Controlled Trial. J Interferon Cytokine Res. 2017 Nov;37(11):480-487.
D1. Sulksomboon N, Poolsup N, et al. Meta-analysis of the effect of herbal supplement on glycemic control in type 2 diabetes. J Ethnopharmacol. 2011;137(3):1328-1333.
D2. Derosa G, D’Angelo A, et al. The role of a fixed Berberis aristata/Silybum marianum combination in the treatment of type 1 diabetes mellitus. Clin Nutr. 2016;33(5):1091-1095.
D3. Voroneanu L, Nistor I, et al. Silymarin in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Diabetes Res. 2016;2016:5147468.
D4. Voroneanu L, Siriopol D, et al. Addition of silymarin to renin-angiotensin system blockers in normotensive patients with type 2 diabetes mellitus and proteinuria: a prospective randomized trial. Int Urol Nephrol. 2017 Dec;49(12):2195-2204.
D5. Ebrahimpour-Koujan S, Gargari BP, et al. Lower glycemic indices and lipid profile among type 2 diabetes mellitus patients who received novel dose of Silybum marianum (L.) Gaertn. (silymarin) extract supplement: A Triple-blinded randomized controlled clinical trial. Phytomedicine. 2018 May 15;44:39-44.
D6. Hadi A, Pourmasoumi M, et al. The effects of silymarin supplementation on metabolic status and oxidative stress in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of clinical trials. Complement Ther Med. 2018 Dec;41:311-319.
E1. Derosa G, Bonaventura A, et al. Berberis aristata/Silybum marianum fixed combination on lipid profile and insulin secretion in dyslipidemic patients. Expert Opin Biol Ther. 2013;13(11):1495-1506.
E2. Derosa G, Bonaventura A, et al. Effects of Berberis aristata/Silybum marianum association on metabolic parameters and adipocytokines in overweight dyslipidemic patients. J Biol Regul Homeost Agents. 2013;27(3):717-728.
E3. Derosa G, Romano D, et al. Berberis aristata/Silybum marianum fixed combination (Berberol(®)) effects on lipid profile in dyslipidemic patients intolerant to statins at high dosages: a randomized, placebo-controlled, clinical trial. Phytomedicine. 2015 Feb 15;22(2):231-237.
F. Inflammatory Bowel Disease
F1. Langhorst J, Wulfert H, et al. Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases. J Crohns Colitis. 2015 Jan;9(1):86-106. doi: 10.1093/ecco-jcc/jju007. Epub 2014 Nov 28. Review. PubMed PMID: 25518050.
G. Nonalcoholic Steatohepatitis
G1. Wah Kheong C, Nik Mustapha NR, et al. A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis. Clin Gastroenterol Hepatol. 2017 Dec;15(12):1940-1949.e8.
H1. Jalloh MA, Gregory PJ, et al. Dietary supplement interactions with antiretrovirals: a systematic review. Int J STD AIDS. 2017 Jan;28(1):4-15.
H2. Asher GN, Corbett AH, et al. Common Herbal Dietary Supplement-Drug Interactions. Am Fam Physician. 2017 Jul 15;96(2):101-107.
H3. Han Y, Guo D, et al. Effect of silymarin on the pharmacokinetics of losartan and its active metabolite E-3174 in healthy Chinese volunteers. Eur J Clin Pharmacol. 2009 Jun;65(6):585-591.
H4. Izzo AA. Interactions between herbs and conventional drugs: overview of the clinical data. Med Princ Pract. 2012;21(5):404-28. doi: 10.1159/000334488. Epub 2012 Jan 11. Review. PubMed PMID: 22236736.
I1. refI1Grant JE, Redden SA, et al. Milk Thistle Treatment for Children and Adults with Trichotillomania: A Double-Blind, Placebo-Controlled, Crossover Negative Study. J Clin Psychopharmacol. 2019 Mar/Apr;39(2):129-134.
J. Ulcerative Colitis
J1. Rastegarpanah M, Malekzadeh R, et al. A randomized, double blinded, placebo-controlled clinical trial of silymarin in ulcerative colitis. Chin J Integr Med. 2015 Dec;21(12):902-6.
Last reviewed March 2020 by EBSCO NAT Review Board Eric Hurwitz, DC
Last Updated: 6/29/2020
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at email@example.com. Our Health Library Support team will respond to your email request within 2 business days.
All rights reserved.